<?xml version="1.0" encoding="UTF-8"?>
<p>There is therefore cause for concern regarding the wellbeing of pregnant women taking aspirin for prophylaxis of pre‐eclampsia and fetal growth restriction. The debate could have resulted in a misunderstanding among both healthcare professionals and pregnant women, leading to withdrawal of prophylactic low‐dose aspirin therapy. Currently, there are no available data regarding the association between the risk of COVID‐19 progression and intake of low‐dose aspirin.</p>
